Is ALSE or QYLD a better dividend investment in 2026?

ALSE currently yields 20000.00% with a 5% 5-year dividend growth rate. QYLD yields 11.92% with -2.1% growth. The better choice depends on your goal: ALSE offers higher current income.

What is the dividend yield difference between ALSE and QYLD?

ALSE has a forward dividend yield of 20000.00% ($2.00/share annually). QYLD yields 11.92% ($2.04/share annually). The yield gap is 19988.08 percentage points.

Home › Compare › ALSE vs QYLD

ALSE vs QYLD: Dividend Comparison 2026

ALSE yields 20000.00% · QYLD yields 11.92%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 ALSE wins by $52481917574412746752.00M in total portfolio value

INVESTMENT

TIME HORIZON10 years

ALSE

● Live price

20000.00%

Share price

$0.01

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$52481917574412746752.00M

Annual income

$51,970,745,957,167,775,000,000,000.00

Full ALSE calculator →

QYLD

Global X Nasdaq 100 Covered Call ETF

● Live price

11.92%

Share price

$17.15

Annual div

$2.04

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$25.4K

Annual income

$5,659.31

Full QYLD calculator →

Portfolio growth — ALSE vs QYLD

📍 ALSE pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	ALSE	QYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, ALSE + QYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

ALSE pays

QYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ALSE

Annual income on $10K today (after 15% tax)

$1,700,000.00/yr

After 10yr DRIP, annual income (after tax)

$44,175,134,063,592,610,000,000,000.00/yr

QYLD

Annual income on $10K today (after 15% tax)

$1,013.51/yr

After 10yr DRIP, annual income (after tax)

$4,810.41/yr

At 15% tax rate, ALSE beats the other by $44,175,134,063,592,610,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ALSE + QYLD for your $10,000?

ALSE: 50%QYLD: 50%

100% QYLD50/50100% ALSE

Portfolio after 10yr

$26240958787206373376.00M

Annual income

$25,985,372,978,583,888,000,000,000.00/yr

Blended yield

99.03%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ALSE buys

QYLD buys

No recent congressional trades found for ALSE or QYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricALSEQYLD

Forward yield	20000.00% ✓	11.92%
Annual dividend / share	$2.00	$2.04 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$52481917574412746752.00M ✓	$25.4K
Annual income after 10y	$51,970,745,957,167,775,000,000,000.00 ✓	$5,659.31
Total dividends collected	$52448189483771600896.00M ✓	$27.1K
Payment frequency	quarterly	monthly
Sector	Stock	ETF

Year-by-year: ALSE vs QYLD ($10,000, DRIP)

Year	ALSE Portfolio	ALSE Income/yr	QYLD Portfolio	QYLD Income/yr	Gap
1← crossover	$2,010,700	$2,000,000.00	$10,352	$1,192.36	+$2.00M → ALSE
2	$377,983,225	$375,831,775.70	$10,830	$1,347.57	+$377.97M → ALSE
3	$66,433,479,469	$66,029,037,418.28	$11,460	$1,539.07	+$66433.47M → ALSE
4	$10,916,985,471,987	$10,845,901,648,955.73	$12,275	$1,777.84	+$10916985.46M → ALSE
5	$1,677,384,363,769,318	$1,665,703,189,314,291.80	$13,323	$2,078.95	+$1677384363.76M → ALSE
6	$240,985,175,079,139,100	$239,190,373,809,905,920.00	$14,667	$2,463.34	+$240985175079.12M → ALSE
7	$32,373,573,631,143,694,000	$32,115,719,493,809,017,000.00	$16,396	$2,960.57	+$32373573631143.68M → ALSE
8	$4,066,766,648,320,630,000,000	$4,032,126,924,535,306,000,000.00	$18,631	$3,612.97	+$4066766648320630.00M → ALSE
9	$477,730,483,406,513,300,000,000	$473,379,043,092,810,300,000,000.00	$21,548	$4,482.15	+$477730483406513344.00M → ALSE
10	$52,481,917,574,412,750,000,000,000	$51,970,745,957,167,775,000,000,000.00	$25,398	$5,659.31	+$52481917574412746752.00M → ALSE

ALSE vs QYLD: Complete Analysis 2026

ALSE — Stock

Alseres Pharmaceuticals, Inc. focuses on developing diagnostic and therapeutic products primarily for disorders in the central nervous system. Its lead product candidate is Altropane, a molecular imaging agent for the diagnosis of Parkinson's disease and dementia. The company was formerly known as Boston Life Sciences, Inc. and changed its name to Alseres Pharmaceuticals, Inc. in June 2007. Alseres Pharmaceuticals, Inc. was founded in 1972 and is based in Auburndale, Massachusetts.

Full ALSE Calculator →

QYLD — ETF

The Global X Nasdaq 100 Covered Call ETF (QYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Nasdaq-100 BuyWrite V2 Index.

Full QYLD Calculator →

📬

Get this ALSE vs QYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ALSE vs SCHD ALSE vs JEPI ALSE vs O ALSE vs KO ALSE vs MAIN ALSE vs XYLD ALSE vs JEPQ ALSE vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.